These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 33161213)
21. The evolution of A beta peptide burden in the APP23 transgenic mice: implications for A beta deposition in Alzheimer disease. Kuo YM; Beach TG; Sue LI; Scott S; Layne KJ; Kokjohn TA; Kalback WM; Luehrs DC; Vishnivetskaya TA; Abramowski D; Sturchler-Pierrat C; Staufenbiel M; Weller RO; Roher AE Mol Med; 2001 Sep; 7(9):609-18. PubMed ID: 11778650 [TBL] [Abstract][Full Text] [Related]
22. Regulation of Alzheimer beta-amyloid precursor trafficking and metabolism. Gandy S; Petanceska S Biochim Biophys Acta; 2000 Jul; 1502(1):44-52. PubMed ID: 10899430 [TBL] [Abstract][Full Text] [Related]
23. Energy inhibition elevates beta-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: possible early events in Alzheimer's disease pathogenesis. Velliquette RA; O'Connor T; Vassar R J Neurosci; 2005 Nov; 25(47):10874-83. PubMed ID: 16306400 [TBL] [Abstract][Full Text] [Related]
24. Physiological mouse brain Abeta levels are not related to the phosphorylation state of threonine-668 of Alzheimer's APP. Sano Y; Nakaya T; Pedrini S; Takeda S; Iijima-Ando K; Iijima K; Mathews PM; Itohara S; Gandy S; Suzuki T PLoS One; 2006 Dec; 1(1):e51. PubMed ID: 17183681 [TBL] [Abstract][Full Text] [Related]
25. Unexpected partial correction of metabolic and behavioral phenotypes of Alzheimer's APP/PSEN1 mice by gene targeting of diabetes/Alzheimer's-related Sorcs1. Knight EM; Ruiz HH; Kim SH; Harte JC; Hsieh W; Glabe C; Klein WL; Attie AD; Buettner C; Ehrlich ME; Gandy S Acta Neuropathol Commun; 2016 Feb; 4():16. PubMed ID: 26916443 [TBL] [Abstract][Full Text] [Related]
27. Enhancing astrocytic lysosome biogenesis facilitates Aβ clearance and attenuates amyloid plaque pathogenesis. Xiao Q; Yan P; Ma X; Liu H; Perez R; Zhu A; Gonzales E; Burchett JM; Schuler DR; Cirrito JR; Diwan A; Lee JM J Neurosci; 2014 Jul; 34(29):9607-20. PubMed ID: 25031402 [TBL] [Abstract][Full Text] [Related]
28. The type of Aβ-related neuronal degeneration differs between amyloid precursor protein (APP23) and amyloid β-peptide (APP48) transgenic mice. Rijal Upadhaya A; Scheibe F; Kosterin I; Abramowski D; Gerth J; Kumar S; Liebau S; Yamaguchi H; Walter J; Staufenbiel M; Thal DR Acta Neuropathol Commun; 2013 Nov; 1(1):77. PubMed ID: 24252227 [TBL] [Abstract][Full Text] [Related]
29. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease. Kuznetsova E; Schliebs R Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514 [TBL] [Abstract][Full Text] [Related]
30. Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease. Mori T; Koyama N; Arendash GW; Horikoshi-Sakuraba Y; Tan J; Town T Glia; 2010 Feb; 58(3):300-14. PubMed ID: 19705461 [TBL] [Abstract][Full Text] [Related]
31. Neutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1-42 and suppresses microglial activity in a transgenic mouse model of Alzheimer's disease. Manczak M; Mao P; Nakamura K; Bebbington C; Park B; Reddy PH Hum Mol Genet; 2009 Oct; 18(20):3876-93. PubMed ID: 19617638 [TBL] [Abstract][Full Text] [Related]
32. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD). Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906 [TBL] [Abstract][Full Text] [Related]
33. Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease. Cao D; Lu H; Lewis TL; Li L J Biol Chem; 2007 Dec; 282(50):36275-82. PubMed ID: 17942401 [TBL] [Abstract][Full Text] [Related]
34. Plant-based chimeric HPV-virus-like particles bearing amyloid-β epitopes elicit antibodies able to recognize amyloid plaques in APP-tg mouse and Alzheimer's disease brains. Gonzalez-Castro R; Acero Galindo G; García Salcedo Y; Uribe Campero L; Vazquez Perez V; Carrillo-Tripp M; Gevorkian G; Gomez Lim MA Inflammopharmacology; 2018 Jun; 26(3):817-827. PubMed ID: 29094307 [TBL] [Abstract][Full Text] [Related]
35. Active full-length DNA Aβ Rosenberg RN; Fu M; Lambracht-Washington D Alzheimers Res Ther; 2018 Nov; 10(1):115. PubMed ID: 30454039 [TBL] [Abstract][Full Text] [Related]
36. Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice. Fitz NF; Cronican AA; Saleem M; Fauq AH; Chapman R; Lefterov I; Koldamova R J Neurosci; 2012 Sep; 32(38):13125-36. PubMed ID: 22993429 [TBL] [Abstract][Full Text] [Related]
37. Maysin and Its Flavonoid Derivative from Centipedegrass Attenuates Amyloid Plaques by Inducting Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer's Mouse Model. Song Y; Kim HD; Lee MK; Hong IH; Won CK; Bai HW; Lee SS; Lee S; Chung BY; Cho JH PLoS One; 2017; 12(1):e0169509. PubMed ID: 28072821 [TBL] [Abstract][Full Text] [Related]
38. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models. Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932 [TBL] [Abstract][Full Text] [Related]
39. Chronic cerebral hypoperfusion alters amyloid-β peptide pools leading to cerebral amyloid angiopathy, microinfarcts and haemorrhages in Tg-SwDI mice. Salvadores N; Searcy JL; Holland PR; Horsburgh K Clin Sci (Lond); 2017 Aug; 131(16):2109-2123. PubMed ID: 28667120 [TBL] [Abstract][Full Text] [Related]
40. Heparanase overexpression impedes perivascular clearance of amyloid-β from murine brain: relevance to Alzheimer's disease. Zhang X; O'Callaghan P; Li H; Tan Y; Zhang G; Barash U; Wang X; Lannfelt L; Vlodavsky I; Lindahl U; Li JP Acta Neuropathol Commun; 2021 May; 9(1):84. PubMed ID: 33971986 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]